Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Uk Prospective Diabetes Group
UK Prospective Diabetes Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
The need for large scale randomized evidence without undue emphasis on small trials, meta-analyses or subgroup analyses
C.H. Hennekens, and D. DeMets The need for large scale randomized evidence without undue emphasis on small trials, meta-analyses or subgroup analyses JAMA 302 2009 2361 2362
Effects of intensive glucose lowering in type 2 diabetes
The Action to Control Cardiovascular Risk in Diabetes Study Group
The Action to Control Cardiovascular Risk in Diabetes Study Group H.C. Gerstein, M.E. Miller, and R.P. Byington Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
Data and safety monitoring boards of randomized trials: Emerging principles and practical suggestions
C.H. Hennekens, and D. DeMets Data and safety monitoring boards of randomized trials: emerging principles and practical suggestions Clin Invest 1 2011 1 5
The association between severe symptomatic hypoglycemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of ACCORD Study
D.E. Bonds, M.E. Miller, and R.M. Bergenstal The association between severe symptomatic hypoglycemia and mortality in type 2 diabetes: retrospective epidemiological analysis of ACCORD Study BMJ 340 2010 b4909
Effect of baseline characteristics glycemia treatment approach and glycated hemoglobin concentration on the risks of severe hypoglycemia: Post hoc epidemiological analysis of the ACCORD Study
M.E. Miller, D.E. Bonds, and H.C. Gerstein Effect of baseline characteristics glycemia treatment approach and glycated hemoglobin concentration on the risks of severe hypoglycemia: post hoc epidemiological analysis of the ACCORD Study BMJ 340 2010 b5444
Epidemiologic relationships between A1c and all cause mortality during a median 3.4 year followup of glycemic treatment in the ACCORD trial
For the ACCORD Investigators
M.C. Riddle, W.T. Ambrosius, D.J. Brillon For the ACCORD Investigators Epidemiologic relationships between A1c and all cause mortality during a median 3.4 year followup of glycemic treatment in the ACCORD trial Diabetes Care 33 2010 983 990